Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01756690 · ClinicalTrials.gov registry record
Predicting Lung Injury From Transfusion in Patients With Liver Disease
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 16
- Enrollment target
NCT01756690: Clinical Trial study, sponsored by University of Colorado, Denver.
NCT01756690 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01756690 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 16 participants
- Enrollment target
Study Summary
A certain molecule floating in the blood may represent a risk of lung injury after a transfusion. We are determining whether detection of this molecule on a simple blood clotting test will predict the development of lung injury due to transfusion in bleeding patients with chronic liver disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-10 |
| Est. Completion | 2016-12 |
Why NCT01756690 stopped before completion
NCT01756690 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01756690 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01756690 about?
NCT01756690 is a clinical study titled "Predicting Lung Injury From Transfusion in Patients With Liver Disease". A certain molecule floating in the blood may represent a risk of lung injury after a transfusion. We are determining whether detection of this molecule on a simple blood clotting test will predict the development of lung injury due to transfusion in bleeding patients with chronic liver disease.
What is the current status of trial NCT01756690?
This trial is currently terminated. The enrollment target is 16 participants. The study started on 2011-10. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT01756690?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia